AsphyxDx

Translation of clinical markers for oxygen deficiency in newborns into a new diagnostic tool for the prevention of early infant brain damage and guidance of individualized therapy

OBJECTIVE

  • early detection of oxygen deficiency in newborns to prevent later damage
  • as well as improving the nutritional status of preterm infants

AIM OF THE PROJECT

Development of novel Point-of-Care (PoC)-capable diagnostic systems for the reliable detection of asphyxia

  • quantification of small endogenous metabolites via nanopore-based test system and other rapid tests
  • diagnosis of asphyxia via metabolite panels as biomarkers

TASKS

-> data preparation and analysis

-> statistical and bioinformatic analysis

PARTNERS

Furtwangen University – Profs. Deigner, Kohl, Bucher

Universit├Ątskinderklinik T├╝bingen Prof. Franz

Universit├Ąt Leipzig – Dr. Smith

InfanDx AG